{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:04:11Z","timestamp":1761512651448},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/gme.0b013e318159f190","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T19:21:05Z","timestamp":1236280865000},"page":"730-736","source":"Crossref","is-referenced-by-count":14,"title":["Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease"],"prefix":"10.1097","volume":"15","author":[{"given":"Stefano","family":"Palomba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Manguso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Orio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosamaria","family":"Oppedisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Sacchinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Falbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille","family":"Tolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvio","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Mastrantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-22-20210227","first-page":"1157","article-title":"Altered bone metabolism in inflammatory bowel disease.","volume":"92","author":"Bischoff","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"R2-22-20210227","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00042737-200308000-00003","article-title":"Bone loss associated with gastrointestinal disease: prevalence and pathogenesis.","volume":"15","author":"Vestergaard","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R3-22-20210227","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.amjgastroenterol.2003.11.003","article-title":"Evaluation of bone mineral density in inflammatory bowel disease: current safety focus.","volume":"98","author":"Lichtenstein","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R4-22-20210227","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.gastro.2003.09.027","article-title":"Inflammatory bowel disease and the risk of fracture.","volume":"125","author":"van Staa","year":"2003","journal-title":"Gastroenterology"},{"key":"R5-22-20210227","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/j.1572-0241.2003.07590.x","article-title":"The association between corticosteroid use and development of fractures among IBD patients in a population-based database.","volume":"98","author":"Bernstein","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R6-22-20210227","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gut.51.5.654","article-title":"High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease.","volume":"51","author":"Klaus","year":"2002","journal-title":"Gut"},{"key":"R7-22-20210227","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.2003.026799","article-title":"Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population-based cohort study.","volume":"53","author":"Card","year":"2004","journal-title":"Gut"},{"key":"R8-22-20210227","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s007740070008","article-title":"Glucocorticoid-induced osteoporosis: pathogenesis and management.","volume":"18","author":"Nishimura","year":"2000","journal-title":"J Bone Miner Metab"},{"key":"R9-22-20210227","first-page":"S77","article-title":"Glucocorticoid-induced osteoporosis.","volume":"60","author":"Compston","year":"2003","journal-title":"Horm Res"},{"key":"R10-22-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0149-2918(04)90001-X","article-title":"Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis.","volume":"26","author":"Boling","year":"2004","journal-title":"Clin Ther"},{"key":"R11-22-20210227","first-page":"111","article-title":"Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease.","volume":"22","author":"Dunn","year":"2004","journal-title":"J Bone Miner Metab"},{"key":"R12-22-20210227","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/000348949009900914","article-title":"Inhibition of osteoclast recruitment at a local site by 1-hydroxyethylidene-1,1-bisphosphonate (HEBP).","volume":"99","author":"Adachi","year":"1990","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R13-22-20210227","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI114459","article-title":"Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.","volume":"85","author":"Carano","year":"1990","journal-title":"J Clin Invest"},{"key":"R14-22-20210227","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.","volume":"10","author":"Hughes","year":"1995","journal-title":"J Bone Miner Metab"},{"key":"R15-22-20210227","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"R16-22-20210227","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.bone.2007.03.003","article-title":"Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: similarities and differences.","volume":"40","author":"Boonen","year":"2007","journal-title":"Bone"},{"key":"R17-22-20210227","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/er.2001-3002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis.","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"R18-22-20210227","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00198-005-1945-x","article-title":"Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies.","volume":"16","author":"Boonen","year":"2005","journal-title":"Osteoporos Int"},{"key":"R19-22-20210227","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis.","volume":"75","author":"Mellstrom","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"R20-22-20210227","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1359\/jbmr.2002.17.8.1512","article-title":"The comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis: a meta-regression.","volume":"17","author":"Amin","year":"2002","journal-title":"J Bone Miner Res"},{"key":"R21-22-20210227","first-page":"CD001347","article-title":"Bisphosphonates for steroid induced osteoporosis.","volume":"2","author":"Homik","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"R22-22-20210227","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-005-1927-z","article-title":"Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease.","volume":"16","author":"Palomba","year":"2005","journal-title":"Osteoporos Int"},{"key":"R23-22-20210227","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1572-0241.2004.11481.x","article-title":"A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.","volume":"99","author":"Mantzaris","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R24-22-20210227","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1572-0241.2001.03671.x","article-title":"Practice Parameters Committee of the American College of Gastroenterology: management of Crohn's disease.","volume":"96","author":"Hanauer","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R25-22-20210227","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study.","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"R26-22-20210227","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","article-title":"5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.","volume":"92","author":"Sutherland","year":"1987","journal-title":"Gastroenterology"},{"key":"R27-22-20210227","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/bmj.2.5104.1072","article-title":"Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium: a report on a controlled therapeutic trial.","volume":"2","author":"Truelove","year":"1958","journal-title":"BMJ"},{"key":"R28-22-20210227","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.1.5375.89","article-title":"Variation between observers in describing mucosal appearances in proctocolitis.","volume":"1","author":"Baron","year":"1964","journal-title":"BMJ"},{"key":"R29-22-20210227","first-page":"518","article-title":"Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures.","volume":"10","author":"Kiel","year":"1995","journal-title":"J Bone Miner Res"},{"key":"R30-22-20210227","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.285.15.1996","article-title":"M, Juni P, Bartlett C, CONSORT Group (Consolidated Standards of Reporting of Trials). Value of flow diagrams in reports of randomized controlled trials.","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R31-22-20210227","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/gut.34.11.1543","article-title":"Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease.","volume":"34","author":"Clements","year":"1993","journal-title":"Gut"},{"key":"R32-22-20210227","first-page":"609","article-title":"Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation.","volume":"7","author":"Vogelsang","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R33-22-20210227","first-page":"S292","article-title":"Fluoride therapy in the prevention and treatment of corticosteroid-induced osteoporosis Abstract.","volume":"42","author":"Salinas","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R34-22-20210227","first-page":"CD001983","article-title":"Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.","volume":"2","author":"Cranney","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"R35-22-20210227","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1365-2036.1996.63205000.x","article-title":"A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study.","volume":"10","author":"Bernstein","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"R36-22-20210227","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/gast.2000.16518","article-title":"Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease.","volume":"119","author":"Haderslev","year":"2000","journal-title":"Gastroenterology"},{"key":"R37-22-20210227","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2036.2003.01448.x","article-title":"Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate.","volume":"17","author":"von Tirpitz","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R38-22-20210227","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1365-2036.2003.01794.x","article-title":"A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease.","volume":"18","author":"Bartram","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R39-22-20210227","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/00365520500206467","article-title":"Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.","volume":"41","author":"Stokkers","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"R40-22-20210227","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1572-0241.2006.00372.x","article-title":"A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.","volume":"101","author":"Henderson","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R41-22-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/JCD:7:3:255","article-title":"Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.","volume":"7","author":"Watts","year":"2004","journal-title":"J Clin Densitom"},{"key":"R42-22-20210227","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00223-002-2104-4","article-title":"Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three dimensional microcomputed tomography.","volume":"73","author":"Dufresne","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"R43-22-20210227","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1359\/jbmr.060401","article-title":"Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women.","volume":"21","author":"Zoehrer","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R44-22-20210227","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bone.2006.01.161","article-title":"Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography.","volume":"39","author":"Borah","year":"2006","journal-title":"Bone"},{"key":"R45-22-20210227","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","article-title":"Efficacy of safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial.","volume":"15","author":"Reid","year":"2000","journal-title":"J Bone Miner Res"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-200815040-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:30:28Z","timestamp":1618277428000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-200815040-00022"}},"subtitle":["a prospective, parallel, open-label, two-year extension study"],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e318159f190","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}